Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review
Jonathan I. Silverberg, Mark Boguniewicz, Francisco J. Quintana, Rachael A. Clark, Lara Gross, Ikuo Hirano, Anna M. Tallman, Philip M. Brown, Doral Fredericks, David S. Rubenstein, Kimberly McHale
Topics & Concepts
Aryl hydrocarbon receptorInflammationPsoriasisAtopic dermatitisMedicineImmunologyImmune systemTranscription factorReceptorPharmacologyBiologyInternal medicineBiochemistryGeneDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisAsthma and respiratory diseases